NeuroBo Pharmaceuticals Inc (NRBO)
4.34
-0.24
(-5.24%)
USD |
NASDAQ |
May 22, 16:00
4.83
+0.49
(+11.29%)
Pre-Market: 08:42
NeuroBo Pharmaceuticals Total Liabilities (Quarterly): 6.942M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.942M |
| December 31, 2023 | 6.096M |
| September 30, 2023 | 4.875M |
| June 30, 2023 | 3.983M |
| March 31, 2023 | 10.98M |
| December 31, 2022 | 11.78M |
| September 30, 2022 | 1.619M |
| June 30, 2022 | 1.249M |
| March 31, 2022 | 1.533M |
| December 31, 2021 | 2.202M |
| September 30, 2021 | 1.952M |
| June 30, 2021 | 1.241M |
| March 31, 2021 | 1.009M |
| December 31, 2020 | 3.765M |
| September 30, 2020 | 3.692M |
| June 30, 2020 | 3.214M |
| March 31, 2020 | 3.795M |
| Date | Value |
|---|---|
| December 31, 2019 | 2.176M |
| September 30, 2019 | 3.073M |
| June 30, 2019 | 2.05M |
| March 31, 2019 | 1.712M |
| December 31, 2018 | 17.11M |
| September 30, 2018 | 14.02M |
| June 30, 2018 | 13.76M |
| March 31, 2018 | 14.02M |
| December 31, 2017 | 15.08M |
| September 30, 2017 | 16.26M |
| June 30, 2017 | 5.274M |
| March 31, 2017 | 4.545M |
| December 31, 2016 | 4.122M |
| September 30, 2016 | 1.936M |
| June 30, 2016 | 22.68M |
| March 31, 2016 | 2.252M |
| December 31, 2015 | 16.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.009M
Minimum
Mar 2021
11.78M
Maximum
Dec 2022
3.862M
Average
3.144M
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 51.05B |
| SIGA Technologies Inc | 78.16M |
| Vanda Pharmaceuticals Inc | 108.69M |
| Tenon Medical Inc | 4.396M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.02M |
| Shareholders Equity (Quarterly) | 10.08M |